Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells-Reference-Cited by-同舟云学术

Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells

Published:2019-01-22 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Ruiz Alba,Blanch-Lombarte Oscar,Jimenez-Moyano Esther,Ouchi Dan,Mothe Beatriz,Peña Ruth,Galvez Cristina,Genescà Meritxell,Martinez-Picado Javier,Goulder Philip,Barnard Richard,Howell Bonnie,Clotet Bonaventura,Prado Julia G.

Funder

Instituto de Salud Carlos III

Gilead Sciences

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. The end of AIDS: HIV infection as a chronic disease;Deeks;Lancet,2013

2. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency;Chun;Nat Med.,1995

3. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells;Maldarelli;Science,2014

4. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation;Chomont;Nat Med.,2009

5. The Depsipeptide romidepsin reverses HIV-1 latency in vivo;Søgaard;PLoS Pathog.,2015

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges;Infectious Diseases & Immunity;2024-07-25

2. Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART;eLife;2023-09-19

3. Use of programmed cell death protein 1 (PD-1) inhibitor therapy in HIV-infected patients with advanced cancer: a single-center study from China;Infectious Agents and Cancer;2023-05-30

4. Use of Programmed Cell Death Protein 1 (PD-1) Inhibitor Therapy in HIV-infected Patients with Advanced Cancer:a single-center study from China;2023-01-24

5. HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo;Cells;2022-09-23